Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Endocrinology

• Publication date

  2014-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.12477PMID 24750271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The long-term side effects of postoperative radiation therapy in pituitary adenoma patients

  2015cited by this paper
• Update in mortality in GH-treated patients.

  2013cited by this paper
• Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

  2013influential reference
• Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.

  2013cited by this paper
• Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.

  2013cited by this paper
• Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review.

  2013cited by this paper
• Pituitary disease mortality: is it fiction?

  2013cited by this paper
• Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)

  2013cited by this paper
• Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.

  2013influential reference
• Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.

  2012cited by this paper
• Mortality and socioeconomic status in adults with childhood onset GH deficiency (GHD) is highly dependent on the primary cause of GHD.

  2012cited by this paper
• Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.

  2012cited by this paper
• The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.

  2012cited by this paper
• Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.

  2012cited by this paper
• Overall and cause-specific mortality in GH-deficient adults on GH replacement.

  2012cited by this paper
• Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study

  2012cited by this paper
• Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults.

  2011cited by this paper
• Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.

  2011cited by this paper
• Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency

  2011cited by this paper
• Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

  2011cited by this paper
• Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy

  2011cited by this paper
• Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency

  2011influential reference
• Long-term safety of growth hormone replacement after CNS irradiation.

  2011cited by this paper
• Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

  2010cited by this paper
• Long-term safety of recombinant human growth hormone in children.

  2010cited by this paper
• Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database).

  2010cited by this paper
• Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

  2010influential reference
• The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study.

  2010cited by this paper
• GH replacement in patients with non‐functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence

  2009cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2009cited by this paper
• Growth hormone and bone

  2009cited by this paper
• Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.

  2009cited by this paper
• Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.

  2008cited by this paper
• Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.

  2007influential reference
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.

  2007cited by this paper
• Morbidity and GH deficiency: a nationwide study.

  2007influential reference
• Fracture Incidence in GH‐Deficient Patients on Complete Hormone Replacement Including GH

  2007cited by this paper
• Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.

  2006cited by this paper
• GH replacement does not increase the risk of recurrence in patients with craniopharyngioma

  2006cited by this paper
• Increased Prevalence of Radiological Spinal Deformities in Adult Patients With GH Deficiency: Influence of GH Replacement Therapy

  2006influential reference
• Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

  2005cited by this paper
• Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.

  2005cited by this paper
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

  2004cited by this paper
• Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

  2004cited by this paper
• Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.

  2004influential reference
• Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study.

  2002cited by this paper
• Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

  2002cited by this paper
• Incidence of a second tumor in hypopituitary patients operated for pituitary tumors.

  2001cited by this paper
• A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

  2001cited by this paper
• Body composition and quality of life in adults with growth hormone deficiency; effects of low‐dose growth hormone replacement

  2001cited by this paper
• The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density

  2001influential reference
• Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour?

  2001cited by this paper
• Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.

  2001cited by this paper
• Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

  2001cited by this paper
• Association between premature mortality and hypopituitarism

  2001cited by this paper
• Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.

  2000cited by this paper
• Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.

  2000cited by this paper
• Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

  2000cited by this paper
• Cost of Illness in Adult Patients with Hypopituitarism

  2000cited by this paper
• GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

  1999influential reference
• Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency.

  1999cited by this paper
• The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency

  1998cited by this paper
• Increased incidence of neoplasia in patients with pituitary adenomas

  1998cited by this paper
• Growth hormone and bone.

  1998cited by this paper
• Increased cerebrovascular mortality in patients with hypopituitarism

  1997cited by this paper
• Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.

  1997cited by this paper
• The effect of hypopituitarism on life expectancy.

  1996cited by this paper
• Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

  1996cited by this paper
• Clinical aspects of growth hormone deficiency in adults.

  1995influential reference
• The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.

  1995cited by this paper
• The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.

  1995cited by this paper
• The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.

  1994cited by this paper
• Cardiovascular risk factors in adult patients with growth hormone deficiency.

  1993cited by this paper
• Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.

  1991influential reference
• Premature mortality due to cardiovascular disease in hypopituitarism.

  1990cited by this paper
• Beneficial effects of growth hormone treatment in GH-deficient adults.

  1989cited by this paper
• The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

  1989cited by this paper

• Glymphatic system dysfunction in pediatric growth hormone deficiency evidenced by multiple MRI metrics

  2025cites this paper
• Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study)

  2025cites this paper
• Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors

  2024cites this paper
• Sex differences in long-term safety and tolerability of Growth Hormone (GH) Replacement Therapy in GH deficient adults.

  2023cites this paper
• Unusual and lesser-known rare causes of adult growth hormone deficiency.

  2023cites this paper
• The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency

  2023cites this paper
• Effect of growth hormone cotreatment in sub-fertile women ≥ 40 years: a meta-analysis

  2023cites this paper
• Regulation of ovarian function by growth hormone: Potential intervention of ovarian aging

  2023cites this paper
• Growth hormone in fertility and infertility: Mechanisms of action and clinical applications

  2022cites this paper
• und Alter

  2022cites this paper
• Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

  2022cites this paper
• Paraneoplastic autoimmune hypophysitis: An emerging concept.

  2021cites this paper
• Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients

  2021influential citation
• Growth Hormone Deficiency in Young Cancer Survivors

  2020cites this paper
• Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study

  2020cites this paper
• The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH.

  2020cites this paper
• The Potential Role of Growth Hormone on the Endometrium in Assisted Reproductive Technology

  2020cites this paper
• Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity.

  2020cites this paper
• Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.

  2019cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.

  2019cites this paper
• Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With EasypodTM Connect

  2019cites this paper
• The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review

  2019cites this paper
• Prevalence of diabetes among children treated with growth hormone in Israel

  2019cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 2

  2018cites this paper
• Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment

  2018cites this paper
• Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls

  2018cites this paper
• Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis

  2018cites this paper
• Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 2

  2018cites this paper
• External Beam Radiotherapy in Thyroid Carcinoma: Clinical Review and Recommendations of the AIRO “Radioterapia Metabolica” Group

  2017cites this paper
• Bone health and body composition of children and adolescents with growth hormone deficiency

  2017cites this paper
• Growth Hormone Replacement Therapy in Adult Growth Hormone Deficiency and Risk of Cancer: A Meta-Analysis

  2017cites this paper
• Controversies in the risk of neoplasia in GH deficiency.

  2017cites this paper
• The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke

  2017cites this paper
• The diagnostic ability of core needle biopsy in nodular thyroid disease

  2017cites this paper
• GH deficiency in adult survivors of childhood cancer.

  2016cites this paper
• Two decades of growth hormone treatment in adulthood.

  2016cites this paper
• Two decades of growth hormone treatment in adulthood.

  2016cites this paper
• Growth hormone deficiency in treated acromegaly.

  2015cites this paper
• Efecto de la hormona de crecimiento sobre la proliferación y supervivencia de la línea celular de cáncer de próstata LNCaP

  2015cites this paper
• Chapter 42 - Miscellaneous Hormones

  2015cites this paper
• Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

  2015cites this paper
• Hormone therapy in Fanconi anemia

  2015cites this paper
• Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.

  2015cites this paper
• Gender-Specific Associations of Serum Insulin-Like Growth Factor-1 With Bone Health and Fractures in Older Persons.

  2015cites this paper
• The complex relationship between obesity and the somatropic axis: the long and winding road.

  2014cites this paper
• Summary and General Discussion of the Thesis

  year unknowncites this paper